Sapphire Medical Clinics has won an award for ‘Bringing Treatment to the Masses’ for the Curaleaf Access Scheme.
Despite over three years of medical cannabis legalisation in the UK, many patients still face significant barriers to treatment. That’s what makes the Curaleaf Access Scheme so important. Patients benefit from significant cost savings in recognition of their contribution to The UK Medical Cannabis registry, a ground-breaking initiative that is rapidly expanding the evidence base for medical cannabis.
Canex is awarding its ‘Bringing Treatment to the Masses’ award to Sapphire Medical Clinics for their dedication to improving medical cannabis access. Read more at https://canex.co.uk/bringing-treatment-to-the-masses-sapphire-access-scheme/
Dr Mikael Sodergren, Managing Director at Sapphire Medical Clinics – “Thank you Canex for this award! We are thrilled to retain our multi-award-winning status going into 2022 and expand access to medical cannabis to thousands more patients via our access scheme.”
